Literature DB >> 29594659

Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers.

Athena Puski1,2, Shelly Hovick3, Leigha Senter4, Amanda Ewart Toland4,5.   

Abstract

Deciding between increased cancer screening or prophylactic surgery and the timing of such procedures can be a difficult and complex process for women with BRCA mutations. There are gaps in our understanding of involvement of others in the decision-making process for women with BRCA mutations. This study evaluated the management decision-making process of women with BRCA mutations, focusing on the involvement of others. Grounded theory was used to analyze and code risk management decision-making information from interviews with 20 BRCA mutation carriers. Unaffected at-risk participants with a BRCA mutation, those under age 40, and those with no children described having a difficult time making risk management decisions. Physicians were an integral part of the decision-making process by providing decisional support and management recommendations. Family members and other mutation carriers filled similar yet distinct roles by providing experiential information as well as decisional and emotional support for carriers. Participants described genetic counselors as short-term providers of risk information and management recommendations. The study findings suggest that unaffected at-risk women, women under 40, and those who do not have children may benefit from additional support and information during the decision-making process. Genetic counselors are well trained to help women through this process and connect them with resources, and may be under-utilized in long-term follow-up for women with a BRCA mutation.

Entities:  

Keywords:  BRCA1; BRCA2; Cancer risk management; Decision-making; Genetic counselor; HBOC

Mesh:

Year:  2018        PMID: 29594659      PMCID: PMC6612901          DOI: 10.1007/s10897-018-0254-4

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  30 in total

1.  A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report.

Authors:  Robert Resta; Barbara Bowles Biesecker; Robin L Bennett; Sandra Blum; Susan Estabrooks Hahn; Michelle N Strecker; Janet L Williams
Journal:  J Genet Couns       Date:  2006-04       Impact factor: 2.537

2.  The carrier clinic: an evaluation of a novel clinic dedicated to the follow-up of BRCA1 and BRCA2 carriers--implications for oncogenetics practice.

Authors:  E K Bancroft; I Locke; A Ardern-Jones; L D'Mello; K McReynolds; F Lennard; Y Barbachano; J Barwell; L Walker; G Mitchell; H Dorkins; C Cummings; J Paterson; Z Kote-Jarai; A Mitra; S Jhavar; S Thomas; R Houlston; S Shanley; R A Eeles
Journal:  J Med Genet       Date:  2010-05-14       Impact factor: 6.318

3.  Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers.

Authors:  Xinglei Chai; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Peter J Hulick; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joanne L Blum; Susan M Domchek; Jinbo Chen; Timothy R Rebbeck
Journal:  Breast Cancer Res Treat       Date:  2014-10-14       Impact factor: 4.872

4.  Decision making after BRCA genetic testing. Down the road of transition.

Authors:  Laurie M Connors; Nicoleta Voian; Yi Shi; Robin M Lally; Stephen Edge
Journal:  Clin J Oncol Nurs       Date:  2014-06       Impact factor: 1.027

5.  Lack of shared decision making in cancer screening discussions: results from a national survey.

Authors:  Richard M Hoffman; Joann G Elmore; Kathleen M Fairfield; Bethany S Gerstein; Carrie A Levin; Michael P Pignone
Journal:  Am J Prev Med       Date:  2014-06-09       Impact factor: 5.043

6.  Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction.

Authors:  A Fuchsia Howard; Lynda G Balneaves; Joan L Bottorff; Patricia Rodney
Journal:  Qual Health Res       Date:  2010-10-27

7.  Peer-support in coping with medical uncertainty: discussion of oophorectomy and hormone replacement therapy on a web-based message board.

Authors:  Regina H Kenen; Pamela J Shapiro; Susan Friedman; James C Coyne
Journal:  Psychooncology       Date:  2007-08       Impact factor: 3.894

8.  The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication.

Authors:  Robert Klitzman; Wendy Chung
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

9.  Developments in Clinical Practice: Follow up Clinic for BRCA Mutation Carriers: a Case Study Highlighting the "Virtual Clinic".

Authors:  Audrey Ardern-Jones; Rosalind Eeles
Journal:  Hered Cancer Clin Pract       Date:  2004-02-15       Impact factor: 2.857

10.  International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

Authors:  Kelly A Metcalfe; Daphna Birenbaum-Carmeli; Jan Lubinski; Jacek Gronwald; Henry Lynch; Pal Moller; Parviz Ghadirian; William D Foulkes; Jan Klijn; Eitan Friedman; Charmaine Kim-Sing; Peter Ainsworth; Barry Rosen; Susan Domchek; Teresa Wagner; Nadine Tung; Siranoush Manoukian; Fergus Couch; Ping Sun; Steven A Narod
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

View more
  2 in total

1.  Should pretest genetic counselling be required for patients pursuing genomic sequencing? Results from a survey of participants in a large genomic implementation study.

Authors:  Joel E Pacyna; Carmen Radecki Breitkopf; Sarah M Jenkins; Erica J Sutton; Caroline Horrow; Iftikhar J Kullo; Richard R Sharp
Journal:  J Med Genet       Date:  2018-12-22       Impact factor: 6.318

Review 2.  Family Adjustment to Hereditary Cancer Syndromes: A Systematic Review.

Authors:  Pedro Gomes; Giada Pietrabissa; Eunice R Silva; João Silva; Paula Mena Matos; Maria Emília Costa; Vanessa Bertuzzi; Eliana Silva; Maria Carolina Neves; Célia M D Sales
Journal:  Int J Environ Res Public Health       Date:  2022-01-30       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.